Ropes & Gray LLP

Seventh Circuit Rejects False Claims Act and Retaliation Claims Premised on Purported Breach of Contract

On October 11, 2016, the Seventh Circuit confirmed that there is no violation of the False Claims Act (“FCA”) where the defendant allegedly violated a self-imposed requirement that was not mandated by its contract with the…more
| Civil Remedies, Government Contracting, Labor & Employment Law

The UK to Ratify the Unified Patent Court Agreement

The UK government announced on November 28, 2016 that it will proceed to ratify the Unified Patent Court Agreement (UPCA). The announcement comes after months of uncertainty over the future of the UPCA following the UK’s vote in…more
| Elections & Politics, Intellectual Property, International Law & Trade

ISS and Glass Lewis Update Their Proxy Voting Guidelines for the 2017 Proxy Season

Institutional Shareholder Services Inc. (ISS) and Glass, Lewis & Co. (Glass Lewis) have both released updates to their respective proxy voting guidelines. This Alert provides a brief summary of the significant changes to each…more
| Business Organizations, Securities Law

EU Reaches Final Agreement on Conflict Minerals Regulation – An Overview

On November 22, the EU Council, Commission and Parliament reached an informal final agreement on a conflict minerals regulation. Last week’s agreement builds upon the “political agreement” reached during June…more
| Business Organizations, Elections & Politics, International Law & Trade

MACRA Final Rule and Post-Election Questions

The Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) and the October 14, 2016 final rule from the Centers for Medicare & Medicaid Services (CMS) that implemented it (the Rule) brought a clear end to the plagued…more
| Elections & Politics, Health

FDA Indefinitely Delays Action on Regulating Laboratory Developed Tests

On November 18, 2016, the Food and Drug Administration (FDA) notified industry groups that it no longer plans to finalize its draft guidance on laboratory developed tests (LDTs). FDA stated that it intends to work with the new…more
| Health, Science, Computers, & Technology

SEC Adopts Optional Swing Pricing Rule

In an October 13, 2016 release (the “Release”) the SEC amended Rule 22c-1 to permit, but not require, an open-end fund (other than an ETF or a money market fund) to implement “swing pricing.”1 Swing pricing allows a fund to…more
| Business Organizations, Securities Law

SEC Issues Interpretive Guidance for Up-C Structures Permitting Holding Period Tacking under Rule 144 for Unit-for-Share Exchanges

On November 1, 2016, the staff of the Securities and Exchange Commission (the “SEC”) issued interpretive guidance concluding that in Up-C structures the holding period of LLC units or other partnership interests (the “OP Units”)…more
| Business Organizations, Securities Law

Recent Developments in Japanese Enforcement of Foreign Bribery Laws

In recent years, Japan has been under increasing scrutiny and pressure from the international community regarding its enforcement of its anti-corruption laws. A signatory to the OECD Anti-Bribery Convention, Japan enacted an…more
| Business Organizations, International Law & Trade

New Related-Party Debt Rules Target Earnings Stripping

On October 13, 2016, the Treasury Department and Internal Revenue Service released Final and Temporary regulations under section 385 (the “Regulations”) that broadly impact the tax treatment of certain related-party debt issued…more
| Business Organizations, Taxation

Trump and the Death Tax

Donald Trump’s tax plan calls for elimination of the “death tax,” which refers to the federal estate and generation-skipping transfer (“GST”) taxes, and may include the federal gift tax. His plan also calls for imposition of a…more
| Elections & Politics, Taxation, Wills, Trusts, & Estate Planning

FDA Holds Public Hearing on Manufacturer Communication of Scientific and Medical Information

On November 9 and 10, 2016, FDA held a public hearing to obtain input on manufacturer communications involving unapproved uses of approved or cleared medical products (i.e., “off-label” uses). The hearing was moderated by Leslie…more
| Administrative Law, Science, Computers, & Technology

Recent Proxy Access Developments

To date, nearly 300 companies have adopted proxy access bylaws, including over 40% of S&P 500 companies. Given the widespread adoption of proxy access by large U.S. companies, it was only a matter of time before a shareholder…more
| Business Organizations, Securities Law

Recent Decisions Highlight Legal Risks Associated with Product Cybersecurity Vulnerabilities

Last month, plaintiffs in two product cybersecurity class actions were partially successful in surviving motions to dismiss, continuing the recent trend by plaintiffs and regulatory agencies to expand the pool of defendants in…more
| Antitrust & Trade Regulation, Civil Procedure, Constitutional Law, Privacy, Products Liability

Trumping Obamacare: Some Likely Effects of the Election on Health Care

Just last week, House Speaker Paul Ryan acknowledged that a Hillary Clinton presidency would have cemented the Affordable Care Act (Obamacare) into American life. With the election of Donald Trump, the future of Obamacare looks…more
| Elections & Politics, Health
Showing 1-15 of 937 Results
|
View per page
Page: of 63
Contact

Prudential Tower
800 Boylston Street
Boston, MA 02199-3600, United States

  • 617 951 7000
  • 617 951 7050

Areas of Practice
  • Antitrust & Trade Regulation
  • Appellate Practice
  • Art, Entertainment, & Sports Law
  • Bankruptcy
  • Business Organizations
  • Commercial Law & Contracts
  • Communications & Media Law
  • Environmental Law
  • Finance & Banking
  • Government
  • Health
  • Insurance
  • Intellectual Property
  • International Law & Trade
  • Labor & Employment Law
  • Litigation
  • Mergers & Acquisitions
  • Privacy
  • Real Estate
  • Science, Computers, & Tech
  • Securities Law
  • Taxation
See more
Locations
Other U.S. Locations
  • California
  • D.C.
  • Illinois
  • New York
Other Countries
  • Hong Kong
  • Japan
  • United Kingdom
Number of Attorneys

1,000+ Attorneys

This profile may constitute attorney advertising. Prior results do not guarantee a similar outcome. Any correspondence with this profile holder does not constitute a client/attorney relationship. Neither the content on this profile nor transmissions between you and the profile holder through this profile are intended to provide legal or other advice or to create an attorney-client relationship.

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:

Sign up to create your digest using LinkedIn*

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.

Already signed up? Log in here

*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.
×